GlassScriptPhysician profile
Amanda Nicols
NPI 1720273535
$5,832.89
in general payments reported to CMS, 2019-2025
46 companies · $461 in 2025
The $461 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,503 · 2020: $724 · 2021: $1,037 · 2022: $603 · 2023: $863 · 2024: $642 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,966.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $995.59 | 2019 | |
| Abbvie INC. | $905.43 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $440.73 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $406.88 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $297.65 | 2019-2024 | |
| Coopersurgical, INC. | $254.45 | 2019-2021 | |
| Exeltis, USA INC. | $232.50 | 2020-2024 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $183.40 | 2019-2024 | Trintellix |
| Lupin INC. | $159.60 | 2019-2020 | |
| Gynesonics, INC. | $141.05 | 2021 | |
| Shield Therapeutics INC | $137.38 | 2022-2024 | Accrufer |
| Hologic Sales and Service, LLC | $127.54 | 2023-2025 | Myosure Tissue Removal Device, Novasure |
| Medtronic, INC. | $121.51 | 2024 | Ligasure |
| Bayer Healthcare Pharmaceuticals INC. | $117.19 | 2019-2025 | |
| Organon LLC | $117.08 | 2022-2024 | Nexplanon, Nuvaring |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Nicols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.